Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study.
about
Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.Developing TRAIL/TRAIL death receptor-based cancer therapies.Effects of Recombinant Circularly Permuted Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) (Recombinant Mutant Human TRAIL) in Combination with 5-Fluorouracil in Human Colorectal Cancer Cell Lines HCT116 and SW480.
P2860
Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Circularly permuted TRAIL plus ...... iple myeloma: a phase 2 study.
@en
Circularly permuted TRAIL plus ...... iple myeloma: a phase 2 study.
@nl
type
label
Circularly permuted TRAIL plus ...... iple myeloma: a phase 2 study.
@en
Circularly permuted TRAIL plus ...... iple myeloma: a phase 2 study.
@nl
prefLabel
Circularly permuted TRAIL plus ...... iple myeloma: a phase 2 study.
@en
Circularly permuted TRAIL plus ...... iple myeloma: a phase 2 study.
@nl
P2093
P2860
P921
P1476
Circularly permuted TRAIL plus ...... tiple myeloma: a phase 2 study
@en
P2093
Haitao Meng
Hongyan Pang
Jianmin Wang
Jianyong Li
P2860
P2888
P304
P356
10.1007/S00280-017-3310-0
P50
P577
2017-05-12T00:00:00Z